AngioDynamics (NASDAQ:ANGO) Issues Quarterly Earnings Results

AngioDynamics (NASDAQ:ANGO - Get Free Report) posted its quarterly earnings data on Tuesday. The medical instruments supplier reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.09, RTT News reports. The business had revenue of $80.16 million during the quarter, compared to the consensus estimate of $74.26 million. AngioDynamics had a negative net margin of 14.61% and a negative return on equity of 3.73%. The company's quarterly revenue was up 13.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.06) earnings per share. AngioDynamics updated its FY 2026 guidance to -0.350--0.250 EPS.

AngioDynamics Stock Performance

Shares of NASDAQ ANGO traded down $0.98 during mid-day trading on Tuesday, reaching $8.65. The company had a trading volume of 3,040,367 shares, compared to its average volume of 595,625. The stock has a fifty day moving average of $9.88 and a two-hundred day moving average of $10.08. The company has a market capitalization of $351.28 million, a price-to-earnings ratio of -8.56 and a beta of 0.60. AngioDynamics has a 12-month low of $5.83 and a 12-month high of $13.50.

Wall Street Analyst Weigh In

Separately, HC Wainwright reaffirmed a "buy" rating and set a $16.00 price objective (up from $15.00) on shares of AngioDynamics in a research note on Monday, April 7th.

Institutional Trading of AngioDynamics

An institutional investor recently raised its position in AngioDynamics stock. Jane Street Group LLC increased its position in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 267.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 46,803 shares of the medical instruments supplier's stock after buying an additional 34,054 shares during the period. Jane Street Group LLC owned 0.12% of AngioDynamics worth $439,000 at the end of the most recent reporting period. 89.43% of the stock is currently owned by hedge funds and other institutional investors.

AngioDynamics Company Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.